Actos Buyers Drop Generic Cos. From Pay-For-Delay Appeal
Actos diabetes drug buyers who urged the Second Circuit last month to reverse a lower court ruling dismissing their pay-for-delay suit against Takeda and generic-drug makers for not plausibly showing the...To view the full article, register now.
Already a subscriber? Click here to view full article